(2HRA) H&R GmbH & Co. KGaA - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A2E4T77

2HRA EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of 2HRA over the last 5 years for every Quarter.

2HRA Revenue

This chart shows the Revenue of 2HRA over the last 5 years for every Quarter.

2HRA: Chemicals, Lubricants, Plastics, Petroleum, Specialties

H&R GmbH & Co. KGaA is a global manufacturer and supplier of specialty chemicals and precision plastic parts, operating across Europe, Africa, Asia, and beyond. The companys diversified product portfolio caters to various industries, including pharmaceuticals, automotive, medical technology, and construction. With a rich history dating back to 1919, H&R has established itself as a reliable partner for businesses seeking high-quality chemical-pharmaceutical raw materials and custom-molded plastic components.

The companys business is structured around three key segments: ChemPharm Refining, ChemPharm Sales, and Plastics. ChemPharm Refining is responsible for producing a range of crude oil-based specialty products, including paraffins, white oils, and lubricants, while ChemPharm Sales focuses on distributing these products to various industries. The Plastics segment, meanwhile, develops and manufactures precision plastic parts and components for demanding applications, such as medical consumables and automotive components.

Analyzing the companys , we observe a current price of 4.11 EUR, with short-term moving averages (SMA20: 3.96, SMA50: 4.01) indicating a relatively stable trend. The stocks 52-week high and low (5.00 EUR and 3.27 EUR, respectively) suggest a moderate level of volatility. Considering the , H&Rs market capitalization stands at 150.75M EUR, with a price-to-earnings ratio of 13.97, indicating a relatively reasonable valuation.

By combining the insights from and , we can forecast a potential price target for H&R GmbH & Co. KGaA. Given the companys stable trend, reasonable valuation, and the current ATR of 0.19 (4.66%), we can anticipate a potential short-term price movement within the range of 3.92 EUR to 4.30 EUR. If the company can maintain its current operational momentum and navigate the challenges in the commodity chemicals market, a potential price target of 4.50 EUR could be achievable in the medium term, representing a 9.5% upside from the current price.

To validate this forecast, it is essential to monitor H&Rs future earnings reports, industry trends, and macroeconomic factors that may impact the demand for its products. A thorough analysis of the companys financials, management decisions, and competitive positioning will be crucial in determining whether the predicted price target can be achieved.

Additional Sources for 2HRA Stock

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

2HRA Stock Overview

Market Cap in USD 211m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Commodity Chemicals
IPO / Inception

2HRA Stock Ratings

Growth Rating -17.4
Fundamental 7.34
Dividend Rating 21.9
Rel. Strength 5.04
Analysts -
Fair Price Momentum 5.06 EUR
Fair Price DCF 8.78 EUR

2HRA Dividends

Dividend Yield 12m 2.32%
Yield on Cost 5y 2.03%
Annual Growth 5y 0.00%
Payout Consistency 47.5%
Payout Ratio 33.7%

2HRA Growth Ratios

Growth Correlation 3m 71.2%
Growth Correlation 12m 12.5%
Growth Correlation 5y -66.2%
CAGR 5y 0.09%
CAGR/Max DD 5y 0.00
Sharpe Ratio 12m -0.09
Alpha -0.78
Beta 0.068
Volatility 18.49%
Current Volume 21.9k
Average Volume 20d 11.1k
What is the price of 2HRA shares?
As of June 24, 2025, the stock is trading at EUR 4.94 with a total of 21,935 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +1.21%, over three months by +20.01% and over the past year by +3.71%.
Is H&R GmbH & Co. KGaA a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, H&R GmbH & Co. KGaA is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 7.34 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of 2HRA is around 5.06 EUR . This means that 2HRA is currently overvalued and has a potential downside of 2.43%.
Is 2HRA a buy, sell or hold?
H&R GmbH & Co. KGaA has no consensus analysts rating.
What are the forecasts for 2HRA share price target?
According to our own proprietary Forecast Model, 2HRA H&R GmbH & Co. KGaA will be worth about 5.5 in June 2026. The stock is currently trading at 4.94. This means that the stock has a potential upside of +10.73%.
Issuer Target Up/Down from current
Wallstreet Target Price 5.2 5.3%
Analysts Target Price - -
ValueRay Target Price 5.5 10.7%